Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Curaleaf Holdings Inc (CURA.CN)

Curaleaf Holdings Inc (CURA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Curaleaf Holdings Inc 420 Lexington Avenue Suite 2035 New York NY 10170-0052 USA

P: 781-451-0150

Description:

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

Key Statistics

Overview:

Market Capitalization, $K 3,832,539
Shares Outstanding, K 734,203
Annual Sales, $ 1,336 M
Annual Net Income, $ -370,098 K
Last Quarter Sales, $ 333,172 K
Last Quarter Net Income, $ -92,347 K
60-Month Beta 1.36
% of Institutional Shareholders 0.23%

Growth:

1-Year Return -23.24%
3-Year Return -67.78%
5-Year Return -11.53%
5-Year Revenue Growth 133.35%

Per-Share Information:

Most Recent Earnings -0.13 on 11/13/23
Next Earnings Date N/A
Earnings Per Share ttm -0.66
EPS Growth vs. Prev Year 247.37%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/15/18

CURA.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -34.89%
Return-on-Assets % -14.12%
Profit Margin % -27.69%
Debt/Equity 0.67
Price/Sales 1.97
Price/Book 2.58
Book Value/Share 2.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar